Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Choi Jung. Director active across 2 companies, notably Global Blood Therapeutics, Inc.. In total, 12 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €119k. Activity tracked since 31 August 2021. The latest transaction was filed on 1 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
Choi Jung is a declarant linked to Annexon, Inc. as Director, and to Global Blood Therapeutics, Inc. with the role listed as See Remarks. The profile covers 12 filings, with buys totaling EUR 119183 and no sells in the sampled filings between 2016-01-07 and 2025-12-03, and the most frequent transaction nature is option exercise.